Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a New Screening Test of Cognitive Impairment Among Multiple Sclerosis Patients

NCT03999034 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT03999034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03999034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a New Screening Test of Cognitive Impairment Among Multiple Sclerosis Patients
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Not applicable
Overall status
Unknown status
Start date
July 8, 2019
Completion date
October 8, 2020
Enrollment
540 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive dysfunction, sclerosis, multiple